High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
• women with at least 2 times the normal risk of developing breast cancer
• between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative)
• greater than six months from ingestion of antihormonal therapy
• greater than 1 year from pregnancy, lactation, or chemotherapy
• willing to have a mammogram within six months prior to RPFNA
• willing to discontinue NSAIDS or herbal supplements
• willing to have blood drawn